Related Experiment Video

Updated: Aug 17, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck

Sichuan Xi1, Qing Zhang, Kevin F Dyer

  • 1Department of Otolaryngology, University of Pittsburgh School of MedicinePennsylvania 15213, USA.

The Journal of Biological Chemistry
|May 29, 2003
PubMed

Insights

Src kinases activate Signal Transducer and Activator of Transcription (STAT) proteins, promoting head and neck squamous cell carcinoma (SCCHN) growth. Inhibiting Src kinases reduces STAT activation and SCCHN cell proliferation, suggesting a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Signal transducer and activator of transcription (STAT) proteins are frequently activated in malignancies like head and neck squamous cell carcinoma (SCCHN).
  • Epidermal growth factor receptor (EGFR) phosphorylation is previously linked to STAT 3 and 5 activation in SCCHN.

Purpose of the Study:

  • To investigate the role of Src family kinases in STAT activation and SCCHN cell growth.
  • To elucidate the relationship between Src kinases, STATs, and EGFR in SCCHN.

Main Methods:

  • Expression and activation analysis of Src family kinases (c-Src, c-Yes, Fyn, Lyn) in SCCHN cell lines.
  • Correlation analysis between Src phosphotyrosine levels and STAT 3/5 activation.
  • Co-immunoprecipitation to detect protein interactions (c-Src, STATs, EGFR).
  • In vitro studies using Src-specific inhibitors and dominant-negative c-Src constructs to assess STAT activation and cell growth.

Main Results:

  • Src family kinases were expressed and activated in SCCHN cells but not normal cells.
  • High correlation observed between Src phosphotyrosine levels and STAT 3/5 activation in SCCHN.
  • c-Src interacts with STATs 3/5 and EGFR; no STAT3-STAT5 heterodimerization detected.
  • Src inhibition or dominant-negative c-Src reduced STAT 3/5 activation and SCCHN cell growth in vitro.

Conclusions:

  • Src kinases play a crucial role in mediating STAT 3/5 activation in conjunction with EGFR in SCCHN.
  • Targeting Src activation presents a potential therapeutic strategy for SCCHN and other cancers with elevated EGFR and STATs.

More Related Videos

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...